Johnson & Johnson is selling the assets of Laminar, a company it acquired in November 2023 for its left atrial appendage closure technology. This divestiture comes three years after the initial acquisition, signaling a strategic portfolio adjustment.
Johnson & Johnson Divests Laminar LAA Closure Assets
Johnson & JohnsonMedTechDivestitureHealthcareCorporate Strategy



